A preprint is now available on bioRxiv:
https://www.biorxiv.org/cgi/content/short/2026.01.28.702195v1
NewsLepton announced today that its manuscript introducing Castling, a novel therapeutic concept for rewiring pathological gene-expression networks enabled by its TRIPLE™ technology, has been submitted for peer review.
January 14, 2026by admin
